BiomeBank is a clinical stage biotechnology company developing microbial therapies
BiomeBank has raised $10.8M in total funding. The most recent round was Corporate Round. The last funding was announced in April 2026.
BiomeBank's investors include Ellerston Capital, South Australian Venture Capital Fund, Blackmores.
BiomeBank is headquartered in Adelaide, Australia.
BiomeBank is a clinical stage biotechnology company developing microbial therapies
BiomeBank is at the Corporate Round stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"BiomeBank — Funding & Investors." VCBacked, April 17, 2026, https://www.vcbacked.co/company/biomebank. Accessed September 29, 2026.
VCBacked. (2026). BiomeBank — Funding & Investors. Retrieved September 29, 2026, from https://www.vcbacked.co/company/biomebank
{{cite web |title=BiomeBank — Funding & Investors |url=https://www.vcbacked.co/company/biomebank |website=VCBacked |access-date=September 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated